Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Seshu Tyagarajan Insider Profile
4 Followers
Seshu Tyagarajan, CTO at Candel Therapeutics, holds 125.66K shares in Candel Therapeutics (Ticker: CADL). Most recently, Seshu Tyagarajan Sold $20,392 shares of Candel Therapeutics on Dec 03, 2024 for an estimated value of 92.78K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-56.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Seshu Tyagarajan's holdings
Insider Roles
CTO
Roles that Seshu Tyagarajan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Seshu Tyagarajan
Seshu Tyagarajan's Trading History
List of latest transactions for each holding click on a transaction to see Seshu Tyagarajan's performance on stock
You May Also Like
Seshu Tyagarajan insider profile FAQ
What is the percentage of profitable transactions made by Seshu Tyagarajan?
The percentage of profitable transactions made by Seshu Tyagarajan is 0%.
What is the average return per transaction made by Seshu Tyagarajan?
The average return per transaction made by Seshu Tyagarajan is -56.90%.
What stocks does Seshu Tyagarajan hold?
Seshu Tyagarajan holds: CADL stocks.
What was Seshu Tyagarajan’s latest transaction?
Seshu Tyagarajan latest transaction was an Informative Sell of $92.78K.
What was Seshu Tyagarajan's most profitable transaction?
Seshu Tyagarajan’s most profitable transaction was an Informative Sell of CADL stock on July 15, 2024. The return on the trade was -32.10%.
What is Seshu Tyagarajan's role in Candel Therapeutics?
Seshu Tyagarajan's role in Candel Therapeutics is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.